Musculoskeletal pain can restrict mobility, affect daily activities and lead to prolonged dependence on pain medication. Conventional treatment options may not always be convenient for continuous home use. Litemed is addressing this gap through wearable, non-invasive light-based pain management.
Its flagship product, CURAPOD, is a wearable device that uses photobiomodulation (low-level red and near-infrared light therapy) to support musculoskeletal pain management. The company has also introduced CURAPOD-M, extending its technology to menstrual pain management and women's health.
Proof
CURAPOD has undergone a double-blind, randomised, placebo-controlled, multicentre clinical study, published in JMIR Biomedical Engineering in April 2026. The company states that the device received CDSCO approval as a Class B medical device in December 2025.
People
Litemed was founded in 2022 by Sri Velliyur (Co-founder and CEO) and Surya Maguluri (Co-founder and CTO). The founding team brings together engineering, pharmaceutical and healthcare experience to develop clinically informed, technology-driven pain management solutions.
Purse
In February 2026, Litemed announced backing from V3 Ventures, 3i Partners and Ideaspring Capital. The company has not disclosed the investment amount on its official website.
Plan
Litemed plans to expand CURAPOD's reach across India while strengthening manufacturing, distribution and clinical partnerships. It is also investing in product and app innovation, expanding its wearable portfolio and exploring international markets, including Europe and the US.
Why it matters
Pain management remains a significant healthcare challenge, particularly for people living with recurring musculoskeletal conditions. Litemed's work represents an effort to bring wearable, non-invasive therapeutic technology into everyday settings while building India's capabilities in medical-device innovation and manufacturing.
|
Particulars |
Details |
|---|---|
|
Company |
Litemed India Private Limited |
|
Brand |
Litemed / CURAPOD |
|
Inception |
2022 |
|
Headquarters |
Hyderabad, Telangana |
|
Industry |
MedTech, HealthTech, Wearable Medical Devices |
|
Founders |
Sri Velliyur and Surya Maguluri |
|
Key Products |
CURAPOD, CURAPOD-M |
|
Core Technology |
Photobiomodulation / Low-Level Light Therapy |
|
Funding |
Investment announced in February 2026; amount not disclosed on company website |
|
Investors |
V3 Ventures, 3i Partners, Ideaspring Capital |
|
Website |